Yahoo
OTC Markets OTCQB USD

Nu-Med Plus, Inc. (NUMD)

0.0072 0.0000 (0.00%)
At close: October 30 at 5:00:00 PM EDT
Chart Range Bar
Loading chart for NUMD
  • Previous Close 0.0072
  • Open 0.0072
  • Bid 0.0073 x 2000000
  • Ask 0.0107 x 2000000
  • Day's Range 0.0072 - 0.0072
  • 52 Week Range 0.0072 - 0.0300
  • Volume 10,000
  • Avg. Volume 16,505
  • Market Cap (intraday) 601,549
  • Beta (5Y Monthly) -1.97
  • PE Ratio (TTM) --
  • EPS (TTM) 0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Nu-Med Plus, Inc., a medical device company, engages in the design, innovation, development, enhancement, and commercialization of medical devices worldwide. The company develops a nitric oxide generating formulation; a hospital bedside nitric oxide delivery system; a clinical unit for use in medical clinics and rehabilitation centers. It is also involved in the development of a mobile rechargeable device to deliver nitric oxide gas; and a nitric oxide system that can be used for research applications, as well as a mobile/portable rechargeable device to deliver inhaled nitric oxide gas. Nu-Med Plus, Inc. was incorporated in 2011 and is based in Port Jefferson, New York.

www.nu-medplus.com

2

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NUMD
58.33%
S&P 500 (^GSPC)
10.73%

1-Year Return

NUMD
76.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

NUMD
62.11%
S&P 500 (^GSPC)
81.91%

5-Year Return

NUMD
89.74%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -329.49%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -20.79k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.41k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -138.28k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: